Company / Gross Margin
TEVA PHARMACEUTICAL INDUSTRIES LTD Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
51.8%
FY2025
5-year range
46.7% / 51.8%
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
#19 of 28
Health Care
What the data says
At 51.8%, TEVA PHARMACEUTICAL INDUSTRIES LTD's gross margin ranks #19 of 28 in the Health Care sector. Gross Margin has increased for 3 consecutive years, from 46.7% in FY2022 to 51.8% in FY2025.
Based on SEC 10-K filings.
51.8% in FY2025 with a 5-year CAGR of +5.4%.
Improved from 48.3% to 51.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +5.1pp
- 5-Year Change
- +5.4pp
- 10-Year Change
- -
Sector benchmark
#19 of 28 in Health CareTop 68% of 28This company 51.8% Sector average 60.3%
▼
-14.1% below sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 6.3% year-over-year.
- Currently 8.5pp below the Health Care sector average.
- Peak gross margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 51.8% | +6.3% |
| FY2024 | 48.7% | +1.0% |
| FY2023 | 48.3% | +3.3% |
| FY2022 | 46.7% | -2.3% |
| FY2021 | 47.8% | +3.1% |
| FY2020 | 46.4% | +3.9% |
| FY2019 | 44.6% | -1.7% |
| FY2018 | 45.4% | -6.5% |
| FY2017 | 48.6% | -8.7% |
| FY2016 | 53.2% | -7.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026